2023 U.S.-Booked Air Volume: $32.5 million
Primary Global Online Booking Tool: SAP Concur
Primary Global Expense Supplier: SAP Concur
Primary Global Payment Provider: Bank of America
Primary Global Travel Risk Management Provider: International SOS
Consolidated Global TMC: BCD   

Japan-headquartered pharmaceutical company Takeda spent $32.5 million on 2023 U.S.-booked air travel, up from $31.2 million in 2022.   

Domestic volume accounts for 85 percent of all travel. Takeda’s business travel has recovered to pre-pandemic levels and it returned to offices in 2023.  

The company in 2023 reviewed its traditional travel management company model and considered the effects of allowing travelers to book flights, hotels and rental cars online via other channels, including directly with suppliers, where Takeda's corporate discounts could be applied and duty of care would remain intact. It also completed a skills gap assessment across its Meetings and Travel Center of Excellence to identify critical skill gaps across the global team.

In 2024, Takeda is implementing a new data analytics tool to enhance data-driven decision-making and to gain the ability to provide stakeholders with cleaner and more meaningful data. It also is exploring AI technology to replace human intervention when answering common questions and to provide travel policy information and advice to its travelers.   

The company made minor travel policy changes to remove outdated and redundant content, refresh language and to align with industry standards. Internal travel in 2023 was 49 percent of total travel compared with 52 percent in 2022 and a projected 48 percent in 2024. About 63 percent of its U.S.-booked air was done so via its preferred online booking tool, with 85 percent completed with no agent assistance.

Takeda reported fiscal-year 2024 revenue of $28.2 billion, an increase of 5.9 percent year over year. Its fiscal year ends March 31.